Researchers established the efficacy of combining neratinib (N) with trastuzumab (T) and support clinical testing to investigate the efficacy of N + T with or without chemotherapy in the neoadjuvant setting for HER2+ breast cancer.
[npj Breast Cancer]
Sorry, but the selected Zotpress account can't be found.